Claude Sonnet 4.6 beats Opus in agentic tasks, adds 1 million context, and excels in finance and automation, all at one-fifth ...
Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results